77 FR 134 pg. 41190 - Revised Document Posted: NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012, Correction
Type: NOTICEVolume: 77Number: 134Page: 41190
Docket number: [Docket Number NIOSH-190]
FR document: [FR Doc. 2012-17002 Filed 7-11-12; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number NIOSH-190]
Revised Document Posted: NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012, Correction
AGENCY:
National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
ACTION:
A notice of issuance of Final Guidance Publication was published in the Federal Register June 27, 2012, (77 FR 38297). This notice is corrected as follows:
On page 38297, the Docket number has been changed to NIOSH-190.
FOR FURTHER INFORMATION CONTACT:
Barbara MacKenzie, NIOSH, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS-C26, Cincinnati, OH 45226, Telephone (513) 533-8132, email hazardousdrugs@cdc.gov .
Dated: July 6, 2012.
John Howard,
Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.
[FR Doc. 2012-17002 Filed 7-11-12; 8:45 am]
BILLING CODE 4163-19-P